Evidence map›Paper›PMID 35573157›Full record

ArticleAsian bioethics review2022

Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives.

Haruka Nakada, Kyoko Takashima, Yuichi Maru, Tsunakuni Ikka, Koichiro Yuji, Sachie Yoshida, Kenji Matsui

Open access · bronzeAbstract read
In one paragraph

Article in Asian bioethics review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Haruka NakadaDivision of Bioethics and Healthcare Law, Institute for Cancer Control, National Cancer Center Japan, Tokyo, Japan.ORCID 0000-0003-1856-4640
Kyoko TakashimaOffice of Bioethics, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1116-2374
Yuichi MaruFaculty of Regional Sciences, Tottori University, Tottori, Japan.
Tsunakuni IkkaDivision of Bioethics and Healthcare Law, Institute for Cancer Control, National Cancer Center Japan, Tokyo, Japan.
Koichiro YujiProject Division of International Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9168-4991
Sachie YoshidaLiberal Arts Center, Hyogo University of Health Sciences, Hobe, Hyogo Japan.
Kenji MatsuiDivision of Bioethics and Healthcare Law, Institute for Cancer Control, National Cancer Center Japan, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9390-2959
Hyogo University of Health Sciences · JPNational Center for Global Health and Medicine · JPSaitama International Medical Center · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improving public understanding and acceptance are critical for promoting coronavirus (COVID-19) vaccination. However, how to promote COVID-19 vaccine programs remains controversial due to various ethical issues. This study, thus, aimed to survey the acceptance of COVID-19 vaccines among Japanese citizens and discuss relevant ethical issues. A cross-sectional survey was conducted via an online platform. An anonymous, quantitative, self-administered online questionnaire was sent to 6965 registered Japanese residents (20-79 years of age), which included questions regarding the respondent's general knowledge, experience, and opinions of vaccines, vaccine development, COVID-19, and COVID-19 vaccines. Of the 1569 respondents, 730 (46.5%) and 839 (53.5%) were categorized into the younger and older groups, respectively. Most of the respondents possessed general knowledge of COVID-19 vaccines and their features. Of the respondents, 57.8% definitely agreed (10.5%) or somewhat agreed (47.3%) to receive COVID-19 vaccines. The older group showed significantly greater willingness to receive vaccines and higher literacy regarding vaccines in general. Possible reasons for the older group's greater willingness to receive COVID-19 vaccines are a high risk of severe COVID-19 infection and their past accumulated experience of receiving various vaccinations. Although active public intervention could increase vaccination rates, most of the respondents did not agree with mandatory vaccination. Furthermore, a gap between the participants in the COVID-19 vaccine trials and the prioritized population in real-world vaccination should be adjusted in future vaccine development. Supplementary Information: The online version contains supplementary material available at 10.1007/s41649-022-00207-4.

Indexed as

COVID-19SARS-CoV-2VaccineVaccine acceptance

Identifiers

PMID35573157
PMCPMC9091544
OpenAlexW4280536582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.